Photo taken from Drew Moghanaki/X
Sep 17, 2023, 18:35
Drew Moghanaki: Here is a trio of ongoing adjuvant studies for patients with stage IA NSCLC.
Drew Moghanaki, at , shared on Twitter:
“Here is a trio of ongoing adjuvant studies for patients with stage IA NSCLC. If either is positive, patients with stage IA may soon have to choose between Surgery+Observe and SBRT+ICI.”
Source: Drew Moghanaki/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 20, 2025, 20:33
Jan 20, 2025, 20:31
Jan 20, 2025, 20:26
Jan 20, 2025, 20:21
Jan 20, 2025, 20:12
Jan 20, 2025, 20:10
Jan 20, 2025, 20:08
Jan 20, 2025, 20:06
Jan 20, 2025, 20:03